tiprankstipranks
Trending News
More News >
LakeShore Biopharma (LSBCF)
OTHER OTC:LSBCF
US Market

LakeShore Biopharma (LSBCF) Financial Statements

Compare
92 Followers

LakeShore Biopharma Financial Overview

LakeShore Biopharma's market cap is currently $35.23M. The company's EPS TTM is $; its P/E ratio is ―; LakeShore Biopharma is scheduled to report earnings on January 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 614.96M¥ 573.42M¥ 687.20M¥ 502.95M¥ 257.02M
Gross Profit¥ 507.19M¥ 455.73M¥ 533.84M¥ 381.49M¥ 197.36M
Operating Income¥ -86.29M¥ -445.83M¥ -139.38M¥ -118.96M¥ -125.85M
EBITDA¥ -48.54M¥ -368.66M¥ -76.80M¥ -67.20M¥ -116.78M
Net Income¥ -99.98M¥ -433.46M¥ -145.48M¥ -236.67M¥ -191.83M
Balance Sheet
Cash & Short-Term Investments¥ 28.08M¥ 246.35M¥ 370.11M¥ 271.07M¥ 390.46M
Total Assets¥ 1.37B¥ 1.51B¥ 1.72B¥ 201.03M¥ 91.37K
Total Debt¥ 414.40M¥ 424.46M¥ 498.63M¥ 380.59M¥ 18.70M
Net Debt¥ 386.32M¥ 178.11M¥ 128.52M¥ 379.70M¥ -371.75M
Total Liabilities¥ 867.91M¥ 927.82M¥ 991.30M¥ 20.35M¥ 70.01K
Stockholders' Equity¥ 499.75M¥ 585.21M¥ 728.45M¥ 671.25M¥ 776.60M
Cash Flow
Free Cash Flow¥ -138.84M¥ -339.48M¥ -239.52M¥ -299.55M¥ -351.49M
Operating Cash Flow¥ -120.98M¥ -295.23M¥ -182.47M¥ -613.23K¥ -246.61M
Investing Cash Flow¥ -17.01M¥ -44.25M¥ -56.98M¥ -298.92M¥ -104.24M
Financing Cash Flow¥ -3.58M¥ 205.26M¥ 317.45M¥ 364.56M¥ 739.26M
Currency in CNY

LakeShore Biopharma Earnings and Revenue History

LakeShore Biopharma Debt to Assets

LakeShore Biopharma Cash Flow

LakeShore Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.